MK-2 Inhibitor III
|
MK-2 INHIBITOR III (COMPOUND 16)
|
1186648-22-5
|
AD80
|
AD80
|
1384071-99-1
|
AL 8697
|
AL 8697
|
1057394-06-5
|
SR-318
|
1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl-
|
2413286-32-3
|
BI-D1870
|
BI-D1870
|
501437-28-1
|
PD318088
|
5-溴-N-(2,3-二羥基丙氧基)-3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯甲酰胺
|
391210-00-7
|
VX-11e
|
VX11E
|
896720-20-0
|
Agerafenib
|
CEP 32496
|
1188910-76-0
|
B-Raf inhibitor 1
|
N1-(4-氯苯基)-6-甲基-N5-[3-(9H-嘌呤-6-基)-2-吡啶]-1,5-異喹啉二胺
|
1093100-40-3
|
Tanzisertib
|
TANZISERTIB
|
899805-25-5
|
HG6-64-1
|
CS-1301
|
1315329-43-1
|
5Z-7-Oxozeaenol
|
(5Z)-7-OXOZEAENOL
|
253863-19-3
|
TC ASK 10
|
化合物 T13099
|
1005775-56-3
|
AX-15836
|
2035509-96-5
|
2035509-96-5
|
MW-150
|
MW-150
|
1628502-91-9
|
AZ 628
|
AZ 628
|
878739-06-1
|
AT7867
|
AT7867
|
857531-00-1
|
ERK5-IN-1
|
ERK5-IN-1
|
1234479-76-5
|
NG25
|
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺
|
1315355-93-1
|
p38 MAPK-IN-1
|
CS-2117
|
1006378-90-0
|
GW806742X
|
CS-2659
|
579515-63-2
|
BMS-582949 hydrochloride
|
BMS-582949 (HYDROCHLORIDE)
|
912806-16-7
|
CC-90003
|
1621999-82-3
|
1621999-82-3
|
PROTAC B-Raf degrader 1
|
PROTAC B-Raf degrader 1
|
2364367-27-9
|
Hypothemycin
|
寄端霉素
|
76958-67-3
|
Regorafenib
|
瑞格非尼
|
755037-03-7
|
Trametinib
|
曲美替尼
|
871700-17-3
|
Pluripotin
|
PLURIPOTIN
|
839707-37-8
|
TAK-580
|
MLN2480
|
1096708-71-2
|
Dabrafenib
|
達(dá)拉非尼
|
1195765-45-7
|
Cobimetinib hemifumarate
|
可美替尼
|
1369665-02-0
|
ETC-206
|
4-[6-[4-(4-嗎啉基羰基)苯基]咪唑并[1,2-A]吡啶-3-基]芐腈
|
1464151-33-4
|
WHI-P258
|
WHI-P258
|
21561-09-1
|
MK-8353
|
化合物 T12069
|
1184173-73-6
|
Tpl2 Kinase Inhibitor 1
|
4-[(3-氯-4-氟苯基)氨基]-6-[(3-吡啶甲基)氨基]-1,7-萘啶-3-甲腈
|
871307-18-5
|
SL327
|
SL 327
|
305350-87-2
|
SB-590885
|
5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氫-1-茚酮肟
|
405554-55-4
|
TAK-733
|
TAK733
|
1035555-63-5
|
AS601245
|
JNK INHIBITOR V CALBIOCHEM
|
345987-15-7
|
Encorafenib
|
康奈非尼
|
1269440-17-6
|
DLK-IN-1
|
化合物 T11056
|
1620574-24-4
|
AZ304
|
AZ304
|
942507-42-8
|
CKI-7 free base
|
CKI-7
|
120615-25-0
|
JWG-071
|
JWG-071
|
2250323-50-1
|
RWJ-67657
|
4-(4-氟苯基)-2-(4-羥基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑
|
215303-72-3
|
Refametinib
|
瑞法替尼
|
923032-37-5
|
SB 203580 hydrochloride
|
869185-85-3
|
869185-85-3
|
Regorafenib Hydrochloride
|
瑞格非尼鹽酸鹽
|
835621-07-3
|
Regorafenib monohydrate
|
瑞格非尼一水合物
|
1019206-88-2
|
LY-2584702 tosylate salt
|
LY2584702 TOSYLATE
|
1082949-68-5
|
AZD7624
|
AZD-7624; AZD 7624; AZD7624
|
1095004-78-6
|
BI-882370
|
BI 882370
|
1392429-79-6
|
UM-164
|
UM-164
|
903564-48-7
|
5,6,7-Trimethoxyflavone
|
黃岑素-5,6,7-三甲醚
|
973-67-1
|
GW284543
|
GW284543 (UNC10225170)
|
790186-68-4
|
Dilmapimod
|
444606-18-2
|
444606-18-2
|
KO-947
|
KO-947
|
1695533-89-1
|
ZM 336372
|
ZM 336372
|
208260-29-1
|
ERK1/2 inhibitor 2
|
ASTX-029
|
2095719-92-7
|
BAY885
|
BAY-885
|
2307249-33-6
|
Belvarafenib
|
BELVARAFENIB
|
1446113-23-0
|
p38α inhibitor 1
|
P38Α INHIBITOR 1
|
1034189-82-6
|
LUT014
|
LUT-014
|
2274819-46-2
|
CMPD1
|
CMPD1
|
41179-33-3
|
FR 180204
|
FR180204
|
865362-74-9
|
RO4987655
|
RO4987655(CH4987655)
|
874101-00-5
|
U0126-EtOH
|
2,3-雙[氨基[(2-氨基苯基)硫]亞甲基]丁二腈乙醇鹽
|
1173097-76-1
|
BIX02188
|
(3Z)-3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯亞甲基]-2,3-二氫-2-氧代-1H-吲哚-6-甲酰胺
|
334949-59-6
|
Dabrafenib Mesylate
|
達(dá)帕菲尼甲磺酸鹽
|
1195768-06-9
|
Cobimetinib racemate
|
1-[[3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯基]羰基]-3-(哌啶-2-基)氮雜環(huán)丁-3-醇
|
934662-91-6
|
LY3009120
|
LY-3009120
|
1454682-72-4
|
Guggulsterone
|
香膠甾酮
|
95975-55-6
|
KY-05009
|
1228280-29-2
|
1228280-29-2
|
TC13172
|
TCI3172
|
2093393-05-4
|
SLV-2436
|
2095704-43-9
|
2095704-43-9
|
Talmapimod
|
他匹莫德
|
309913-83-5
|
BRAF inhibitor
|
N-[2,4-二氟-3-[[5-(3-吡啶基)-1H-吡咯并[2,3-B]吡啶-3-基]羰基]苯基]-2-丙磺酰胺
|
918505-61-0
|
AZD8330
|
2-(2-氟-4-碘苯氨基)-N-(2-羥基乙氧基)-1,5-二甲基-6-氧代-1,6-二氫吡啶-3-甲酰胺
|
869357-68-6
|
JNK Inhibitor VIII
|
JNK INHIBITOR VIII (TCS JNK 6O)
|
894804-07-0
|
GSK-25
|
GSK-25
|
874119-56-9
|
BIX02189
|
BIX 02189
|
1265916-41-3
|
JNK-IN-8
|
JNK-IN-8
|
1410880-22-6
|
AT7867 dihydrochloride
|
4-(4-氯苯基)-4-[4-(1H-吡唑-4-基)苯基]哌啶二鹽酸鹽
|
1431697-86-7
|
CC-401 hydrochloride
|
3-[3-[2-(1-哌啶基)乙氧基]苯基]-5-(1H-1,2,4-三唑-5-基)-1H-吲唑鹽酸鹽
|
1438391-30-0
|
SR-3306
|
化合物SR-3306
|
1128096-91-2
|
SL 0101-1
|
77307-50-7
|
ERK1/2 inhibitor 1
|
ERK1/2 INHIBITOR 1
|
2095719-90-5
|
Sorafenib Tosylate
|
甲苯磺酸索拉非尼
|
475207-59-1
|
Sorafenib
|
索拉非尼
|
284461-73-0
|
Pimasertib
|
N-[(2S)-2,3-二羥基丙基]-3-[(2-氟-4-碘苯基)氨基]-4-吡啶甲酰胺
|
1236699-92-5
|
Bentamapimod
|
本塔馬莫
|
848344-36-5
|
Trametinib (DMSO solvate)
|
曲美替尼二甲亞砜
|
1187431-43-1
|
CCT196969
|
CB93134226
|
1163719-56-9
|
AZD-0364
|
CS-2696
|
2097416-76-5
|
IQ-3
|
IQ 3
|
312538-03-7
|
TBAP-001
|
1777832-90-2
|
1777832-90-2
|
DMX-5804
|
DMX5804;DMX 5804
|
2306178-56-1
|
ERK5-IN-2
|
ERK5-IN-2
|
1888305-96-1
|
(rel)-AR234960
|
(rel)-AR234960
|
1408311-94-3
|
RRD-251
|
(2,4-二氯苯基)甲基硫基甲烷脒鹽酸鹽
|
72214-67-6
|